Scholl Hendrik Peter
Chief Medical Officer
- Shares
- 2
- Price
- $170.02
- Value
- $340.04
BLTE
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$32,100,749
0 buyers · 3 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$40,625,543
5 distinct insiders
Highlighted alerts
13
87 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
BLTE overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/25/2026. Represents the weighted average price of shares sold at prices that ranged from $163.6 to $163.65. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $164.41 to $164.96. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $165 to $165.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $166.06 to $166.77. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $167 to $167.93. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $168.03 to $168.42. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of shares sold at prices that ranged from $169.18 to $169.51. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Reason: rule_10b5_1. The trade is reported under a Rule 10b5-1 plan.
Voluntary purchases and sales; administrative noise stays hidden.
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Chuang Hao-Yuan
Chief Financial Officer
Lin Yu-Hsin
Chief Executive Officer
Lin Yu-Hsin
Chief Executive Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
Scholl Hendrik Peter
Chief Medical Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
MATA NATHAN L.
Chief Scientific Officer
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 01, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 2 | $170.02 | $340.04 | |
| Oct 01, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 14 | $169.36 | $2,371 | |
| Oct 01, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 12 | $168.21 | $2,019 | |
| Oct 01, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 78 | $167.59 | $13,072 | |
| Oct 01, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 50 | $166.44 | $8,322 | |
| Oct 01, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 120 | $165.49 | $19,859 | |
| Oct 01, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 24 | $164.64 | $3,951 | |
| Oct 01, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 200 | $163.63 | $32,725 | |
| Sep 08, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 2,700 | $198.09 | $534,845 | |
| Sep 08, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 8,752 | $197.36 | $1,727,275 | |
| Sep 08, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 6,058 | $196.54 | $1,190,642 | |
| Sep 08, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 6,090 | $195.62 | $1,191,325 | |
| Sep 08, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 2,400 | $194.33 | $466,399 | |
| Sep 08, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 2,562 | $198.05 | $507,392 | |
| Sep 08, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 4,605 | $197.23 | $908,244 | |
| Sep 08, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 4,475 | $196.47 | $879,200 | |
| Sep 08, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 4,120 | $195.60 | $805,889 | |
| Sep 08, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 2,200 | $194.28 | $427,414 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 8,955 | $189.34 | $1,695,552 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 3,045 | $188.26 | $573,253 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 6,200 | $187.25 | $1,160,964 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 7,800 | $186.32 | $1,453,323 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 4,593 | $185.34 | $851,286 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 6,252 | $184.52 | $1,153,647 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 4,955 | $183.30 | $908,228 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 3,413 | $182.50 | $622,869 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 8,111 | $193.13 | $1,566,439 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 4,209 | $192.54 | $810,412 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 11,080 | $191.15 | $2,117,909 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 600 | $190.39 | $114,232 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 2,587 | $181.24 | $468,877 | |
| Sep 04, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 2,635 | $180.29 | $475,071 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 6,200 | $189.22 | $1,173,191 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 1,900 | $188.59 | $358,318 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 3,900 | $187.16 | $729,942 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 4,600 | $186.35 | $857,187 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 3,872 | $185.28 | $717,408 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 3,569 | $184.57 | $658,744 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 3,759 | $183.27 | $688,899 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 2,000 | $182.49 | $364,985 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 4,602 | $193.12 | $888,727 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 3,398 | $192.40 | $653,788 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 6,200 | $191.09 | $1,184,754 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 1,800 | $190.63 | $343,140 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 2,000 | $181.05 | $362,107 | |
| Sep 04, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 1,633 | $180.16 | $294,201 | |
| Aug 12, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 223 | $180.57 | $40,267 | |
| Aug 12, 2026 | Chuang Hao-Yuan Chief Financial Officer | Sale | 144 | $180.00 | $25,920 | |
| Aug 12, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 223 | $180.57 | $40,267 | |
| Aug 12, 2026 | Lin Yu-Hsin Chief Executive Officer | Sale | 142 | $180.00 | $25,560 | |
| Jun 18, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 96 | $147.11 | $14,123 | |
| Jun 18, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 1,199 | $146.24 | $175,348 | |
| Jun 18, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 4,861 | $145.43 | $706,959 | |
| Jun 18, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 3,748 | $144.66 | $542,192 | |
| Jun 18, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 96 | $143.90 | $13,814 | |
| Jun 16, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 1,035 | $145.02 | $150,097 | |
| Jun 16, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 1,897 | $143.55 | $272,314 | |
| Jun 16, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 450 | $142.20 | $63,988 | |
| Jun 16, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 100 | $141.83 | $14,183 | |
| Jun 16, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 540 | $140.58 | $75,915 | |
| Jun 16, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 3,140 | $139.57 | $438,260 | |
| Jun 16, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 784 | $138.18 | $108,331 | |
| Jun 16, 2026 | Scholl Hendrik Peter Chief Medical Officer | Sale | 2,054 | $137.61 | $282,641 | |
| May 07, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 9 | $155.25 | $1,397 | |
| May 07, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 3 | $154.61 | $463.83 | |
| May 07, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 428 | $153.56 | $65,725 | |
| May 07, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 226 | $152.45 | $34,453 | |
| May 06, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 100 | $156.00 | $15,600 | |
| May 06, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 100 | $155.97 | $15,597 | |
| May 06, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 240 | $154.41 | $37,059 | |
| May 06, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 128 | $153.42 | $19,638 | |
| May 06, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 424 | $152.67 | $64,733 | |
| May 06, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 8 | $151.57 | $1,213 | |
| May 05, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 68 | $158.11 | $10,751 | |
| May 05, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 155 | $157.29 | $24,380 | |
| May 05, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 121 | $156.53 | $18,940 | |
| May 05, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 173 | $155.48 | $26,898 | |
| May 05, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 363 | $154.44 | $56,063 | |
| May 05, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 120 | $153.92 | $18,471 | |
| May 04, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 172 | $157.49 | $27,088 | |
| May 04, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 235 | $156.57 | $36,793 | |
| May 04, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 325 | $155.21 | $50,442 | |
| May 04, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 236 | $154.24 | $36,400 | |
| May 04, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 32 | $153.50 | $4,912 | |
| May 01, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 23 | $160.00 | $3,680 | |
| May 01, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 38 | $159.08 | $6,045 | |
| May 01, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 65 | $158.35 | $10,293 | |
| May 01, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 106 | $157.45 | $16,690 | |
| May 01, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 82 | $156.24 | $12,812 | |
| May 01, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 346 | $155.48 | $53,795 | |
| May 01, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 288 | $154.38 | $44,461 | |
| May 01, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 52 | $153.89 | $8,003 | |
| Apr 30, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 101 | $158.15 | $15,973 | |
| Apr 30, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 340 | $157.37 | $53,506 | |
| Apr 30, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 517 | $156.59 | $80,955 | |
| Apr 30, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 42 | $155.68 | $6,538 | |
| Apr 29, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 22 | $158.19 | $3,480 | |
| Apr 29, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 102 | $157.39 | $16,053 | |
| Apr 29, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 339 | $156.43 | $53,030 | |
| Apr 29, 2026 | MATA NATHAN L. Chief Scientific Officer | Sale | 259 | $155.52 | $40,280 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.